Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akebia Therapeutics, Inc. (AKBA) vs Journey Medical Corporation (DERM)

Akebia Therapeutics, Inc. and Journey Medical Corporation are both Drug Manufacturers Specialty & Generic companies. Akebia Therapeutics, Inc. is the larger, with a market value of $254.7M against $178.4M — 1.4× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 7.52%. Journey Medical Corporation has the higher net margin (−8.95% vs −13.5%) and the lower return on invested capital (−5.89% vs 0.00%). Across the 18 metrics below, Journey Medical Corporation leads on 10 and Akebia Therapeutics, Inc. on 8.

Valuation

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.11 2.48 2.25
P/B 9.70 5.26 1.90
Price to free cash flow 6.03 n/m 16.54
EV/EBITDA n/m 96.75 12.29
EV/Sales 0.62 2.47 2.56
Earnings yield (12.00%) (3.58%) (2.99%)
Free cash flow yield 16.59% (13.32%) 0.00%

Profitability

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
Gross margin 79.63% 65.45% 53.94%
Operating margin (6.90%) (4.41%) 0.00%
Net margin (13.54%) (8.95%) 0.00%
Free cash flow margin 18.38% (10.99%) 0.00%
Return on equity (109.38%) (23.77%) (0.40%)
Return on assets (8.53%) (6.80%) (3.32%)
Return on invested capital 0.00% (5.89%) 0.00%

Growth

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.52% 20.89% 10.01%
EPS growth (last fiscal year) 93.94% 34.72% —
Revenue growth, 5-year CAGR (4.33%) 6.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
Debt to equity 1.98 0.79 0.05
Current ratio 1.43 1.59 2.31
Net debt to EBITDA (5.51) (0.35) 0.85

Dividend

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKBA DERM Drug Manufacturers Specialty & Generic median
Market cap 254.66m 178.38m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack